| Guidelines for the use of flow cytometry and cell sorting in immunological studies A Cossarizza, HD Chang, A Radbruch, A Acs, D Adam, S Adam‐Klages, ... European journal of immunology 49 (10), 1457-1973, 2019 | 346 | 2019 |
| Targeting CD38 with daratumumab in refractory systemic lupus erythematosus L Ostendorf, M Burns, P Durek, GA Heinz, F Heinrich, P Garantziotis, ... New England Journal of Medicine 383 (12), 1149-1155, 2020 | 284 | 2020 |
| SARS-CoV-2 in severe COVID-19 induces a TGF-β-dominated chronic immune response that does not target itself M Ferreira-Gomes, A Kruglov, P Durek, F Heinrich, C Tizian, GA Heinz, ... Nature communications 12 (1), 1961, 2021 | 211 | 2021 |
| Pharmacological interventions enhance virus-free generation of TRAC-replaced CAR T cells J Kath, W Du, A Pruene, T Braun, B Thommandru, R Turk, ML Sturgeon, ... Molecular Therapy-Methods & Clinical Development 25, 311-330, 2022 | 69 | 2022 |
| Daratumumab for treatment‐refractory antibody‐mediated diseases in neurology F Scheibe, L Ostendorf, H Prüss, H Radbruch, T Aschman, S Hoffmann, ... European journal of neurology 29 (6), 1847-1854, 2022 | 65 | 2022 |
| Daratumumab treatment for therapy-refractory anti-CASPR2 encephalitis F Scheibe, L Ostendorf, SM Reincke, H Prüss, AC Von Bruenneck, ... Journal of neurology 267, 317-323, 2020 | 63 | 2020 |
| Phasor-based endogenous NAD (P) H fluorescence lifetime imaging unravels specific enzymatic activity of neutrophil granulocytes preceding NETosis R Leben, L Ostendorf, S Van Koppen, A Rakhymzhan, AE Hauser, ... International Journal of Molecular Sciences 19 (4), 1018, 2018 | 38 | 2018 |
| Low-density granulocytes are a novel immunopathological feature in both multiple sclerosis and neuromyelitis optica spectrum disorder L Ostendorf, R Mothes, S Van Koppen, RL Lindquist, J Bellmann-Strobl, ... Frontiers in Immunology 10, 2725, 2019 | 37 | 2019 |
| Dysregulated CD38 expression on peripheral blood immune cell subsets in SLE M Burns, L Ostendorf, R Biesen, A Grützkau, F Hiepe, HE Mei, ... International Journal of Molecular Sciences 22 (5), 2424, 2021 | 34 | 2021 |
| Daratumumab for the treatment of refractory ANCA-associated vasculitis L Ostendorf, M Burns, DL Wagner, P Enghard, K Amann, H Mei, ... RMD open 9 (1), e002742, 2023 | 22 | 2023 |
| SIGLEC1 (CD169): a marker of active neuroinflammation in the brain but not in the blood of multiple sclerosis patients L Ostendorf, P Dittert, R Biesen, A Duchow, V Stiglbauer, K Ruprecht, ... Scientific Reports 11 (1), 10299, 2021 | 19 | 2021 |
| Analyzing nicotinamide adenine dinucleotide phosphate oxidase activation in aging and vascular amyloid pathology H Radbruch, R Mothes, D Bremer, S Seifert, R Köhler, J Pohlan, ... Frontiers in Immunology 8, 844, 2017 | 18 | 2017 |
| Daratumumab for autoimmune diseases: a systematic review MT Holzer, N Ruffer, TB Huber, I Kötter, L Ostendorf, M Krusche RMD open 9 (4), e003604, 2023 | 17 | 2023 |
| Discriminating promiscuous from target‐specific autoantibodies in COVID‐19 M Lebedin, CV García, L Spatt, C Ratswohl, C Thibeault, L Ostendorf, ... European Journal of Immunology 53 (5), 2250210, 2023 | 17 | 2023 |
| 7 Tesla MRI of Balo's concentric sclerosis versus multiple sclerosis lesions JR Behrens, J Wanner, J Kuchling, L Ostendorf, L Harms, K Ruprecht, ... Annals of Clinical and Translational Neurology 5 (8), 900-912, 2018 | 17 | 2018 |
| Sustained responses after anti-CD38 treatment with daratumumab in two patients with refractory systemic lupus erythematosus T Alexander, L Ostendorf, R Biesen, U Schneider, GR Burmester, F Hiepe Annals of the Rheumatic Diseases 82 (11), 1497-1499, 2023 | 13 | 2023 |
| Evaluation of SIGLEC1 in the diagnosis of suspected systemic lupus erythematosus L Zorn-Pauly, ASL von Stuckrad, J Klotsche, T Rose, T Kallinich, ... Rheumatology 61 (8), 3396-3400, 2022 | 12 | 2022 |
| Rescue combination treatment of anti-MDA5-associated ARDS with daratumumab L Ostendorf, F Muench, L Thormählen, Z Galbavý, R Körner, J Nee, ... RMD open 9 (3), e003238, 2023 | 8 | 2023 |
| Increased levels of immature and activated low density granulocytes and altered degradation of neutrophil extracellular traps in granulomatosis with polyangiitis S Lipka, L Ostendorf, U Schneider, F Hiepe, F Apel, T Alexander Plos one 18 (3), e0282919, 2023 | 6 | 2023 |
| CD38 als innovatives therapeutisches Target zur Plasmazelldepletion bei Autoimmunerkrankungen T Alexander, L Ostendorf, F Hiepe Arthritis und Rheuma 44 (02), 120-124, 2024 | | 2024 |
Falk HiepeCharité - Universitätsmedizin Berlin & Deutsches RheumaForschungszentrum Berlin確認したメール アドレス: charite.de
